Launch preparations underway ahead of U.S. PDUFA goal date of September 7, 2025. The sNDA for PYRUKYND for the treatment of adult patients with non-transfusion-dependent and transfusion-dependent ...

As of June 30, 2025, Apellis had $370.0 million in cash and cash equivalents, compared to $411.3 million in cash and cash equivalents as of December 31, 2024. Apellis anticipates its cash, combined ...

Looking to boost your income fast? Discover five good side hustles you can start right now—even with limited time or money.

Detailed price information for Ivanhoe Mines Ltd (IVN-T) from The Globe and Mail including charting and trades.